Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop

被引:245
作者
Eastell, Richard [1 ]
Brandi, Maria Luisa [2 ]
Costa, Aline G. [3 ,4 ]
D'Amour, Pierre [5 ]
Shoback, Dolores M. [6 ]
Thakker, Rajesh V. [7 ]
机构
[1] Univ Sheffield, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England
[2] Univ Florence, I-50133 Florence, Italy
[3] Columbia Univ, Dept Med, Div Endocrinol, Metab Bone Dis Unit,Coll Phys & Surg, New York, NY 10032 USA
[4] Univ Fed Sao Paulo, Dept Med, Div Endocrinol, BR-04021001 Sao Paulo, Brazil
[5] Univ Montreal, Ctr Hosp Univ Montreal, Hop St Luc, Montreal, PQ H3C 3J7, Canada
[6] Univ Calif San Francisco, Endocrine Res Unit, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA
[7] Univ Oxford, Acad Endocrine Unit, Radcliffe Dept Med, Oxford OX3 7LJ, England
基金
英国医学研究理事会;
关键词
VITAMIN-D DEFICIENCY; NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM; MILD PRIMARY HYPERPARATHYROIDISM; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; SPORADIC PARATHYROID ADENOMAS; SENSING RECEPTOR MUTATIONS; NEOPLASIA TYPE-1 MEN1; IMMUNORADIOMETRIC ASSAY; SOMATIC MUTATIONS; CALCIUM EXCRETION;
D O I
10.1210/jc.2014-1414
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem. The purpose of this report is to provide an update on the use of diagnostic tests for this condition in clinical practice. Participants: This subgroup was constituted by the Steering Committee to address key questions related to the diagnosis of PHPT. Consensus was established at a closed meeting of the Expert Panel that followed. Evidence: Each question was addressed by a relevant literature search (on PubMed), and the data were presented for discussion at the group meeting. Consensus Process: Consensus was achieved by a group meeting. Statements were prepared by all authors, with comments relating to accuracy from the diagnosis subgroup and by representatives from the participating professional societies. Conclusions: We conclude that: 1) reference ranges should be established for serum PTH in vitamin D-replete healthy individuals; 2) second-and third-generation PTH assays are both helpful in the diagnosis of PHPT; 3) normocalcemic PHPT is a variant of the more common presentation of PHPT with hypercalcemia; 4) serum 25-hydroxyvitamin D concentrations should be measured and, if vitamin D insufficiency is present, it should be treated as part of any management course; 5) genetic testing has the potential to be useful in the differential diagnosis of familial hyperparathyroidism or hypercalcemia.
引用
收藏
页码:3570 / 3579
页数:10
相关论文
共 59 条
[1]
Normal PTH Levels in Primary Hyperparathyroidism: Still the Same Disease? [J].
Amin, Amanda L. ;
Wang, Tracy S. ;
Wade, Thomas J. ;
Yen, Tina W. F. .
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (12) :3437-3442
[2]
Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional study [J].
Amstrup, Anne Kristine ;
Rejnmark, Lars ;
Vestergaard, Peter ;
Sikjaer, Tanja ;
Rolighed, Lars ;
Heickendorff, Lene ;
Mosekilde, Leif .
CLINICAL ENDOCRINOLOGY, 2011, 74 (01) :130-136
[3]
Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients [J].
Bjoerkman, Mikko ;
Sorva, Antti ;
Risteli, Juha ;
Tilvis, Reijo .
AGE AND AGEING, 2008, 37 (01) :25-31
[4]
Responses of parathyroid hormone to vitamin D supplementation: A systematic review of clinical trials [J].
Bjorkman, Mikko ;
Sorva, Antti ;
Tilvis, Rejo .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2009, 48 (02) :160-166
[5]
Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism [J].
Bollerslev, Jens ;
Marcocci, Claudio ;
Sosa, Manuel ;
Nordenstrom, Jorgen ;
Bouillon, Roger ;
Mosekilde, Leif .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (06) :851-864
[6]
Third- or second-generation parathyroid hormone assays: A remaining debate in the diagnosis of primary hyperparathyroidism [J].
Boudou, P ;
Ibrahim, F ;
Cormier, C ;
Chabas, C ;
Sarfati, E ;
Souberbielle, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6370-6372
[7]
Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy [J].
Boudou, Philippe ;
Ibrahim, Fidaa ;
Cormier, Catherine ;
Sarfati, Emile ;
Souberbielle, Jean-Claude .
JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (02) :240-246
[8]
Potential clinical utility of a new IRMA for parathyroid hormone in postmenopausal patients with primary hyperparathyroidism [J].
Carnevale, V ;
Dionisi, S ;
Nofroni, I ;
Romagnoli, E ;
Paglia, F ;
De Geronimo, S ;
Pepe, J ;
Clemente, G ;
Tonnarini, G ;
Minisola, S .
CLINICAL CHEMISTRY, 2004, 50 (03) :626-631
[9]
Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation [J].
Caron, Philippe ;
Simonds, William F. ;
Maiza, Jean-Christophe ;
Rubin, Mishaela ;
Cantor, Tom ;
Rousseau, Louise ;
Bilezikian, John P. ;
Souberbielle, Jean-Claude ;
D'Amour, Pierre .
CLINICAL ENDOCRINOLOGY, 2011, 74 (06) :694-698
[10]
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods [J].
Christensen, Signe Engkjaer ;
Nissen, Peter H. ;
Vestergaard, Peter ;
Heickendorff, Lene ;
Brixen, Kim ;
Mosekilde, Leif .
CLINICAL ENDOCRINOLOGY, 2008, 69 (05) :713-720